Advertisement

Ads Placeholder
Loading...

Femasys Inc.

FEMYNASDAQ
Healthcare
Medical - Instruments & Supplies
$0.46
$0.04(9.52%)
U.S. Market is Open • 10:37

Femasys Inc. Fundamental Analysis

Femasys Inc. (FEMY) shows moderate financial fundamentals with a PE ratio of -0.93, profit margin of -8.12%, and ROE of -5.35%. The company generates $0.0B in annual revenue with strong year-over-year growth of 51.97%.

Key Strengths

PEG Ratio-0.03

Areas of Concern

ROE-5.35%
Operating Margin-7.67%
Current Ratio0.00
We analyze FEMY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -1113.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-1113.0/100

We analyze FEMY's fundamental strength across five key dimensions:

Efficiency Score

Weak

FEMY struggles to generate sufficient returns from assets.

ROA > 10%
0.00%

Valuation Score

Excellent

FEMY trades at attractive valuation levels.

PE < 25
-0.93
PEG Ratio < 2
-0.03

Growth Score

Moderate

FEMY shows steady but slowing expansion.

Revenue Growth > 5%
51.97%
EPS Growth > 10%
9.68%

Financial Health Score

Moderate

FEMY shows balanced financial health with some risks.

Debt/Equity < 1
0.80
Current Ratio > 1
0.00

Profitability Score

Weak

FEMY struggles to sustain strong margins.

ROE > 15%
-534.91%
Net Margin ≥ 15%
-8.12%
Positive Free Cash Flow
No

Key Financial Metrics

Is FEMY Expensive or Cheap?

P/E Ratio

FEMY trades at -0.93 times earnings. This suggests potential undervaluation.

-0.93

PEG Ratio

When adjusting for growth, FEMY's PEG of -0.03 indicates potential undervaluation.

-0.03

Price to Book

The market values Femasys Inc. at 2.96 times its book value. This may indicate undervaluation.

2.96

EV/EBITDA

Enterprise value stands at -0.41 times EBITDA. This is generally considered low.

-0.41

How Well Does FEMY Make Money?

Net Profit Margin

For every $100 in sales, Femasys Inc. keeps $-8.12 as profit after all expenses.

-8.12%

Operating Margin

Core operations generate -7.67 in profit for every $100 in revenue, before interest and taxes.

-7.67%

ROE

Management delivers $-5.35 in profit for every $100 of shareholder equity.

-5.35%

ROA

Femasys Inc. generates $0.00 in profit for every $100 in assets, demonstrating efficient asset deployment.

0.00%

Following the Money - Real Cash Generation

Operating Cash Flow

Femasys Inc. generates limited operating cash flow of $-17.16M, signaling weaker underlying cash strength.

$-17.16M

Free Cash Flow

Femasys Inc. generates weak or negative free cash flow of $-17.62M, restricting financial flexibility.

$-17.62M

FCF Per Share

Each share generates $-0.60 in free cash annually.

$-0.60

FCF Yield

FEMY converts -1.83% of its market value into free cash.

-1.83%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.93

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.03

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.96

vs 25 benchmark

P/S Ratio

Price to sales ratio

5.64

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.80

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.00

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-5.35

vs 25 benchmark

ROA

Return on assets percentage

0.00

vs 25 benchmark

ROCE

Return on capital employed

4.84

vs 25 benchmark

How FEMY Stacks Against Its Sector Peers

MetricFEMY ValueSector AveragePerformance
P/E Ratio-0.9328.45 Better (Cheaper)
ROE-534.91%763.00% Weak
Net Margin-812.27%-45265.00% (disorted) Weak
Debt/Equity0.800.34 Weak (High Leverage)
Current Ratio0.002795.60 Weak Liquidity
ROA0.00%-16588.00% (disorted) Weak

FEMY outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Femasys Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-7.38%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

11.83%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

6.69%

Industry Style: Defensive, Growth, Innovation

Growing

Fundamental Analysis FAQ